A new scientific and political debate has begun in Florida around the possibility of repurposing cheap generic drugs in the fight against cancer.
At the center of the controversy is ivermectin, an old antiparasitic drug that has been used for decades for certain parasitic infections, but has not been approved by the U.S. Food and Drug Administration as a cancer treatment.
Online publications present the development with sensational headlines, claiming that Florida has launched an official study with a 77-cent pill to treat stage 4 cancer.
The reality is more complex and requires special attention.
What did Florida really announce?
The Florida government announced $60 million in funding for the 2025–2026 fiscal year, through the Florida Cancer Innovation Fund.
The program was created to support innovative and rapid research approaches in the prevention, diagnosis and treatment of cancer.
Its priorities include clinical trials lasting approximately twelve months, nutrition, interventions in rural and underserved areas, and the reuse of inexpensive generic drugs.
Official State documents cite ivermectin as an example.
This means that researchers and hospitals could submit scientific protocols examining its potential use in cancer. It does not mean that the State has already announced that ivermectin treats cancer, nor that every available amount was directed exclusively to it.
Each research proposal is evaluated for its scientific merit, feasibility, safety and measurable results. For human studies, approvals from relevant ethics committees and a comprehensive clinical protocol are required.
Η study of University of Florida
The ICONIC study, sponsored by the University of Florida, has been registered in the official American clinical trial registry.
The study examines the simultaneous administration of ivermectin and immune checkpoint inhibitors in adults with solid tumors.
The researchers are not claiming that the drug already cures cancer. Their goal is to study:
the safety of administration,
the possible side effects,
the appropriate dosage,
and whether the drug may affect the body's immune response to tumors.
It is, therefore, a research procedure and not an established treatment.
The participation of a substance in a clinical trial means that there is a scientific question worth examining. It does not mean that the substance has already been proven to be effective.
Why are old and cheap drugs being tested?
Drug reuse is a recognized field of medical research.
Scientists examine whether a drug approved for one condition can have useful biological effects in a different disease.
The advantage is that for older drugs there is already data on their pharmacology and safety in approved uses.
This does not, however, eliminate the need for new clinical trials.
The dose needed to affect cancer cells may be different from that used to treat parasites. It may also create different interactions with chemotherapy, immunotherapy, or other medications the patient is taking.
These are precisely the questions that need to be answered with organized and controlled studies.
What does the research show so far?
Ivermectin has shown interesting anticancer effects in laboratory studies, in cell cultures, and in experimental models.
Researchers have examined potential mechanisms related to cancer cell proliferation, programmed cell death, and immune system function.
However, a positive result in the lab is not proof that the same drug will be safe and effective in humans.
Many substances can destroy cancer cells in a laboratory dish. Far fewer ultimately prove that they can be administered to patients in the right dose without unacceptable side effects.
The claims about stage 4 cancer
The reference to patients with stage 4 cancer comes mainly from personal testimonies reproduced in podcasts and on social media.
Such stories may arouse reasonable interest and hope, but they cannot by themselves prove that a drug caused the cancer to regress.
A patient may be receiving chemotherapy, radiation therapy, immunotherapy, or other approved treatments at the same time. Without complete medical data, a comparison group, and independent evaluation, it is not possible to know which factor influenced the course of the disease.
This is why formal research has value: it can separate the real therapeutic effect from coincidence, parallel treatment, or a misinterpretation.
The cost of 77 cents
The reference that ivermectin costs 77 cents per pill was used to emphasize that it is a cheap and off-patent drug.
The price, however, is not fixed.
It varies depending on the dosage, manufacturer, pharmacy, insurance coverage, and form of the drug.
Even more importantly, the low cost of a pill does not prove its effectiveness against cancer.
The price is a financial advantage only if it has been previously proven that the treatment works and can be administered safely.
Hope without deception
Florida's decision to allocate public funds to test old and inexpensive drugs is significant.
Patients need new treatments, especially when they are facing aggressive or advanced forms of cancer. The medical community must seriously consider every reasonable scientific possibility, regardless of whether a drug is new and expensive or old and cheap.
But hope must be accompanied by evidence.
The word "study" does not mean "treatment".
The word "probability" does not mean "cure".
And a personal testimony cannot replace a controlled clinical trial.
Be careful with self-medication
No cancer patient should discontinue or change their approved treatment to take ivermectin on their own.
Taking it without medical supervision may cause side effects or dangerous interactions with anticancer and other medications.
Particularly dangerous are veterinary preparations, which may contain different concentrations and ingredients and are not intended for human use.
The FDA points out that claims of “miracle cures” for cancer are a serious red flag. Unproven treatments can cause harm not only because of their side effects, but also because they delay a treatment with proven benefit.
The investigation must proceed.
Greek News & Radio FL supports scientific research and the search for more affordable treatments that will be available to all patients.
The investigation of ivermectin must proceed with transparency, strict protocols, independent evaluation, and publication of all results — whether positive or negative.
If it proves to offer real benefit, it would be an extremely important development.
Until then, however, it should not be considered a treatment for stage 4 cancer.
Florida did not announce a miracle cure.
He decided to fund the search for answers.
And in science, the answers don't come from sensational headlines. They come from data, tests, and real results.
Πηγές
Florida Department of Health – Florida Cancer Innovation Fund
Executive Office of Governor Ron DeSantis
ClinicalTrials.gov – ICONIC, University of Florida
US Food and Drug Administration – Warnings about unproven cancer treatments
AMG News – Original article reviewed
https://www.youtube.com/watch?v=_6jy9hE75Do
go video
https://www.youtube.com/watch?v=ZGYG-A1eQmc
source Sportify – Gluten Free Vegan GFCFSF Foods
photo MustangJoe, https://pixabay.com
Greek News & Radio FL
